What is Aurolate used for?

Aurolate is indicated for Juvenile rheumatoid arthritis, Rheumatoid arthritis.

What development phase is Aurolate in?

Aurolate is FDA-approved (marketed).

What is the generic name of Aurolate?

sodium aurothiomalate is the generic (nonproprietary) name of Aurolate.

Last reviewed 2026-04-20 · How we verify

Aurolate (sodium aurothiomalate)

FDA-approved active Quality 17/100

At a glance

Generic name	sodium aurothiomalate
Drug class	sodium aurothiomalate
Target	Tyrosine-protein kinase Fyn
Therapeutic area	Immunology
Phase	FDA-approved

Approved indications

Juvenile rheumatoid arthritis
Rheumatoid arthritis

Common side effects

No common side effects on file.

Key clinical trials

Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung Cancer (PHASE1)
Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Aurolate CI brief — competitive landscape report
Aurolate updates RSS · CI watch RSS
portfolio CI